西班牙裔肾移植受者长期结局评估
本研究基于2010至2021年美国移植受者科学登记数据,回顾性比较西班牙裔与非西班牙裔白人肾移植受者的死亡及移植物失败或死亡复合结局。结果显示西班牙裔受者调整后死亡风险(HR 0.70)和复合结局风险(HR 0.79)均更低,非美国公民/居民西班牙裔亦呈类似趋势。
要点
- 西班牙裔肾移植受者死亡风险低于非西班牙裔白人(HR 0.70)。
- 西班牙裔受者移植物失败或死亡复合结局风险更低(HR 0.79)。
- 非美国公民/居民西班牙裔受者同样显示更低风险。
核心结论
- 无论公民身份如何,西班牙裔肾移植受者死亡及移植物失败或死亡复合结局发生率均低于非西班牙裔白人受者。
研究设计与样本
- 回顾性队列研究,纳入2010至2021年科学移植受者登记系统中212,559例肾移植受者,其中17%为西班牙裔,47%为非西班牙裔白人。
主要发现
- 西班牙裔受者平均年龄48.8±14.1岁,非西班牙裔白人为53.5±14.0岁。
- 西班牙裔受者平均等待时间18.4个月,非西班牙裔白人为12.7个月。
- 西班牙裔受者拥有私人保险比例28%,非西班牙裔白人为42%。
- 西班牙裔受者调整后死亡风险HR 0.70(95%CI 0.67-0.73),复合结局HR 0.79(95%CI 0.76-0.82)。
- 非美国公民/居民西班牙裔受者死亡HR 0.68(95%CI 0.63-0.74),复合结局HR 0.73(95%CI 0.68-0.78)。
临床怎么用
- 西班牙裔肾移植受者移植后结局优于非西班牙裔白人,但等待时间更长、私人保险比例更低,提示移植前医疗可及性存在差异。
局限性
- 存在选择偏倚、迁移偏倚和鲑鱼偏倚(salmon bias)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Hispanics, the largest ethnic minority group in the United States, experience faster progression of chronic kidney disease (CKD) to kidney failure compared with non-Hispanic White individuals (NHW). Hispanic individuals are less likely to be referred for transplant evaluation, to be listed for transplantation, and to receive a transplant. This study compared kidney transplant outcomes between Hispanic individuals and NHW individuals to gain insights into these health disparities. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Recipients of kidney transplants between 2010 and 2021 using data from the Scientific Registry of Transplant Recipients. EXPOSURE: Hispanic ethnicity compared with NHW. OUTCOME: Death after transplantation and the composite of allograft failure or death. ANALYTICAL APPROACH: Cox proportional models adjusted for donor and recipient characteristics. RESULTS: Among 212,559 kidney allograft recipients, 17% were Hispanic, and 47% were NHW. Hispanic recipients were younger than NHW recipients (mean age, 48.8+14.1 and 53.5+14.0, respectively). The average time on the transplant waitlist was 18.4 months among Hispanic recipients compared with 12.7 months among NHW recipients. Fewer Hispanic recipients (28%) had private health insurance compared with NHW recipients (42%). Hispanic recipients had lower adjusted rates of death and the composite of allograft failure or death compared with NHW recipients (HR, 0.70 [95 % CI, 0.67-0.73]; vs HR, 0.79 [95% CI, 0.76-0.82], respectively). Similar results were observed when comparing Hispanic non-US citizen/US residents to NHW recipients (HR, 0.68 [95 % CI, 0.63-0.74]; vs HR, 0.73 [95% CI, 0.68-0.78], respectively). LIMITATIONS: Selection bias, migration bias, salmon bias. CONCLUSIONS: Irrespective of citizenship status, Hispanic kidney transplant recipients had lower rates of death and a composite outcome of allograft survival or death compared with NHW recipients. Future research on access to transplantation and rates of CKD progression may be warranted to improve clinical outcomes among individuals of Hispanic ethnicity with kidney disease. PLAIN-LANGUAGE SUMMARY: Hispanic patients have a higher burden of chronic kidney disease (CKD) and faster progression to kidney failure when compared with non-Hispanic White (NHW) patients. Hispanic patients experience disparities in access to kidney care, making it harder to undergo transplantation. We evaluated outcomes after kidney transplantation in this population with the goal of gaining insights into these health disparities. We found that Hispanic kidney transplant recipients had lower rates of the composite outcome of death or kidney allograft loss compared with NHW recipients. We also observed a similar benefit in the immigrant and undocumented Hispanic population. Future research on access to transplantation and rates of CKD progression may be warranted to improve clinical outcomes among individuals of Hispanic ethnicity with kidney disease.
引用
- Giusti S, Arrigain S, Lopez R, et al. Evaluating Long-Term Outcomes Among Hispanic Kidney Transplant Recipients. Am J Kidney Dis. 2025. PMID: 40054591. doi:10.1053/j.ajkd.2025.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。